logo-loader

Allogene Therapeutics Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$3.33 billion
Price
27.37 USD
Change
-1.48%
52 weeks high
35.55
52 weeks low
22.20

In brief

Allogene Therapeutics is a clinical stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, we are developing a pipeline of “off-the-shelf” CAR T cell therapy candidates with the goal of delivering readily available cell therapy faster, more reliably and at greater scale to more patients.